NCT02135042 2026-04-03
Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
NRG Oncology
Phase 2/3 Active not recruiting
NRG Oncology
NRG Oncology
University of California, San Diego
Laibin People's Hospital
Emory University
National Cancer Centre, Singapore
Tata Memorial Centre
Sun Yat-sen University
AHS Cancer Control Alberta